Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Xiaoning Yu
Study on the formation mechanism of the digital health information divide and capital-driven pathways among the older adults
Abstract Background: Artificial intelligence and digital health services have expanded access to health information, yet older adults remain vulnerable to a digital health information divide due to unequal digital literacy, resource access, social support, and psychological readiness. However, the multi-capital mechanisms underlying this divide remain insufficiently explained.
Research on Rapid and Non-Destructive Detection of Coffee Powder Adulteration Based on Portable Near-Infrared Spectroscopy Technology
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Development and validation of a combined cuproptosis and immunogenic cell death prognostic model for diffuse large B-cell lymphoma
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma worldwide with a high degree of heterogeneity. Cuproptosis and immunogenic cell death (ICD) have been considered to be vital for tumor progression. However, current understanding of cuproptosis and immunogenic cell death in DLBCL is still very limited. We aim to explore a prognostic model combining cuproptosis and immunogenic cell death in DLBCL.
Development and validation of a combined cuproptosis and immunogenic cell death prognostic model for diffuse large B-cell lymphoma
Research Paper Volume 16, Issue 2 pp 1218—1236 1 Department of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China 2 Department of Geriatrics, Hematology and Oncology Unit, Qilu Hospital of Shandong University, Jinan 250012, China * Equal contribution and share first authorship https://doi.org/10.18632/aging.205399 How to Cite Cite this Article Select the format you require from the list below Click to copy this citation from the text box above or download the citation:...
Efficacy of augmented-dosed surgery versus botulinum toxin A injection for acute acquired concomitant esotropia: a 2-year follow-up
Background/aims This study aims to evaluate the clinical efficacy of botulinum toxin type A (BTXA) injection and augmented-dosed surgery in the treatment of acute acquired concomitant esotropia (AACE), and explore potential risk factors associated with recurrence. Methods A total of 104 patients diagnosed with AACE between October 2020 and January 2021 were included and voluntarily chose to undergo augmented surgery or BTXA injection. The follow-up assessments ended in November 2022.
Lessons from the case law of China’s IP appeals court
On 26 April 2022, World IP Protection Day, the Supreme Court (SPC) issued a report that summarised the updates to IP protection in 2021 from various IP specialised courts and tribunals in China. The report not only introduced the highlights of IP protection in 2021 but also presented recent statistics. In 2021, there were 4,335 newly accepted technical cases and anti-monopoly cases, constituting an increase of 36.4% from the previous year.
China emerges as a key litigation venue for standard essential patents
In the second half of 2020, a couple of rulings on standard essential patent (SEP) cases were issued in China, including anti-suit injunction rulings in Huawei v Conversant, Xiaomi v IDC, and Samsung v Ericsson, and jurisdiction opposition rulings in ZTE v Conversant and OPPO v Sharp. All of the parties involved in the cases are active players in the telecommunication SEP field. Such a SEP ruling boom emphasises the growing importance of China as a SEP litigation venue.
Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization
Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization Corneal neovascularization (CNV) is one of the leading risk factors for vision loss. Anti-angiogenic drugs can theoretically be extended to the treatment of CNV. However, the application of these drugs is often hindered by traditional administration methods, e.g., eye drops, which is ascribed attributed to the unique structure of the cornea and tear film.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Xiaoning
Contact Xiaoning, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack